AspirinWorks(R) Test Now Available Directly To Consumers.

HealthCheckUSA to Provide Nationwide Access

DENVER -- Corgenix Medical Corporation (OTCBB: CONX), worldwide developer and marketer of diagnostic test kits, has entered into an exclusive partnership with HealthcheckUSA.com to provide consumers direct access to the state-of-the-art AspirinWorks[R] Test through HealthcheckUSA's network of over 3,000 patient service centers nationwide at a consumer-friendly price.

Medical studies have shown that aspirin does not have the same effect on everyone; some people may not benefit from their aspirin therapy. The AspirinWorks[R] Test can determine if aspirin is working to suppress the production of thromboxane, the chemical that causes the platelets to become sticky, indicating whether aspirin is eliciting an effect.

Douglass T. Simpson, Corgenix President and Chief Executive Officer said, "The collaboration with HealthCheckUSA and the availability of the AspirinWorks[R] test through their extensive network of locations are important steps to making the test accessible to the general public. HealthCheckUSA's focus on providing direct-to-consumer testing expands our distribution network beyond the traditional clinical laboratory setting. People are more interested in taking charge of their own health; HealthCheckUSA makes this possible by offering valuable tools, such as the AspirinWorks[R] test."

According to Holt Vaughan, President of HealthCheckUSA.com, "The company is delighted to be one of the first to offer the AspirinWorks[R] test directly to consumers. We have researched the AspirinWorks[R] test and think it is a major breakthrough," Vaughan said. "With so many people in this day and age taking aspirin, we believe it is imperative that people understand aspirin does not have the same effect on everyone."

To request an AspirinWorks[R] test without a physician referral, consumers can log onto www.HealthCheckUSA.com or call toll free 1 [phone]. HealthCheckUSA.com forwards the customer the appropriate paperwork, which they can take to the HealthCheckUSA affiliated lab of choice without an appointment. A urine sample is collected and tested. Confidential results are available on the HealthCheckUSA.com Web site within days. For more information about the AspirinWorks[R] Test, visit HealthCheckUSA.com or www.aspirinworks.com.

About HealthCheckUSA

Founded in 1987, San Antonio-based HealthCheckUSA provides health awareness screening tests to customers throughout the United States. The privately held company is affiliated with major national medical laboratories with more than 3,000 draw sites nationwide. For more information, call 1(800) 929-2044.

About Corgenix Medical Corporation

Corgenix is a leader in the development and manufacturing of specialized diagnostic kits for immunology disorders, vascular diseases and bone and joint disorders. Corgenix diagnostic products are commercialized for use in clinical laboratories throughout the world. The company currently sells over 50 diagnostic products through a global distribution network. More information is available at www.corgenix.com.

Statements in this press release that are not strictly historical facts are "forward looking" statements (identified by the words "believe", "estimate", "project", "expect" or similar expressions) within the meaning of the Private Securities Litigation Reform Act of 1995. These statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company's products and services in the marketplace, competitive factors, changes in the regulatory environment, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission. The statements in this press release are made as of today, based upon information currently known to management, and the Company does not undertake any obligation to publicly update or revise any forward-looking statements.